FindTrial
Sign In

A Medical Based Study on Development and Validation of Tongue Diagnostic Parameters-Based Diagnostic Signatures in Coronary Artery Disease Patients with Clopidogrel Resistance after Percutaneous Coronary Intervention

Development and Validation of Tongue Diagnostic Parameters-Based Diagnostic Signatures in Coronary Artery Disease Patients with Clopidogrel Resistance after Percutaneous Coronary Intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046076
Enrollment
Unknown
Registered
2021-05-04
Start date
2021-10-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

Gold Standard:Clinical outcome
Index test:Tongue&#32
Diagnostic&#32
Parameters

Sponsors

The Affiliated Jiangning Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 and 75 years; 2. Diagnosed with coronary heart disease and received PCI. Coronary heart disease is defined according to the 2019 European Society of Cardiology guidelines or the 2019 guidelines for chronic total occlusion percutaneous coronary intervention.

Exclusion criteria

Exclusion criteria: 1. Accompanied by hematological diseases (abnormal coagulation, abnormal prothrombin time, platelets 450x10^9/L); 2. Use drugs that affect blood coagulation and platelet function, such as warfarin within 6 months; 3. Rheumatic heart disease, severe valvular disease, pulmonary heart disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, myocarditis, hyperthyroidism; 4. Severe anemia, malignant tumors, severe liver and kidney dysfunction (chronic kidney disease> stage 4, Child Pugh> grade C), severe immune system and respiratory system diseases, organ transplantation, allergy to clopidogrel or contraindications, 3 Patients with a history of surgery or severe trauma within months.

Design outcomes

Primary

MeasureTime frame
Tongue Diagnostic Parameters;—

Countries

China

Contacts

Public ContactLiang Caihong

Jiangning Hospital Affiliated to Nanjing Medical University

liangbo2018@126.com+86 15181400995

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026